Med Ad News, PharmaLive.com sold

Share this article:

Med Ad News and PharmaLive.com publisher, Engel Publishing Partners, has been acquired by Los Angeles-based Canon Communications, Canon announced today. Financial terms of the deal were not disclosed.

Canon, a division of Apprise Media, produces magazine titles and trade shows focused on the medical device, specialty packaging, materials processing, and plastics processing industries.

Canon currently maintains several medical titles including MD&DI (Medical Device & Diagnostic Industry), Medical Product Manufacturing News, Medical Electronics Manufacturing, European Medical Device Manufacturer and others. Canon's digital media holdings include the medical device design and engineering portal, Medical Device Link; online magazine, Advanced Design & Manufacturing (AD&M) and various e-newsletters and e-publications.

Next month, Canon will launch its BIOMEDevice trade show, to provide “a forum for areas where the pharmaceutical and medical device manufacturing markets are converging,” said Charles McCurdy, Canon CEO.

Engel Publishing, based in Newtown, PA, was established in 1982. Its monthly Med Ad News publication covers business and marketing activities in the pharmaceutical industry.

Engel's R&D Directions title was established in 1995 and is published 10 times a year. R&D Directions' target audience is comprised of research and development professionals at pharmaceutical companies.

PharmaLive.com reports 150,000 unique visitors each month with 65,000 professionals registered to receive its e-newsletters.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...